Flutamide therapy for carcinoma of the prostate.

  title={Flutamide therapy for carcinoma of the prostate.},
  author={R A Airhart and Taylor Barnett and Joseph W. Sullivan and Robert L. Levine and Jurgen Schlegel},
  journal={Southern medical journal},
  volume={71 7},
In our three-year experience with the use of flutamide for the treatment of carcinoma of the prostate, 20 patients with previously untreated stage D carcinoma of the prostate were enrolled in a 12-week double-blind study. Seven patients received 1.5 gm of flutamide daily, seven patients received 0.75 gm of flutamide daily, and six patients received 1.0 mg of diethylstilbestrol daily. Two patients receiving flutamide did not complete the 12-week study. Six patients receiving flutamide and three… CONTINUE READING